留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

基于肿瘤微环境的癌毒病机理论研究

程海波 沈卫星 吴勉华 周仲瑛

程海波, 沈卫星, 吴勉华, 周仲瑛. 基于肿瘤微环境的癌毒病机理论研究[J]. 南京中医药大学学报, 2014, 30(2): 105-107.
引用本文: 程海波, 沈卫星, 吴勉华, 周仲瑛. 基于肿瘤微环境的癌毒病机理论研究[J]. 南京中医药大学学报, 2014, 30(2): 105-107.
CHENG Hai-bo, SHEN Wei-xing, WU Mian-hua, ZHOU Zhong-ying. Pathogenesis Theory of Cancerous Toxin in Tumor Microenvironment[J]. Journal of Nanjing University of traditional Chinese Medicine, 2014, 30(2): 105-107.
Citation: CHENG Hai-bo, SHEN Wei-xing, WU Mian-hua, ZHOU Zhong-ying. Pathogenesis Theory of Cancerous Toxin in Tumor Microenvironment[J]. Journal of Nanjing University of traditional Chinese Medicine, 2014, 30(2): 105-107.

基于肿瘤微环境的癌毒病机理论研究

Pathogenesis Theory of Cancerous Toxin in Tumor Microenvironment

  • 摘要: 肿瘤的发生、发展不仅取决于肿瘤细胞本身,而且与肿瘤微环境关系密切。目前恶性肿瘤的治疗新策略已转变为通过干预肿瘤微环境,阻断癌变的发生和发展。国医大师周仲瑛教授根据其长期临床实践提出癌毒病机理论,认为癌毒是肿瘤发生、发展的关键。研究认为癌毒病机理论与肿瘤微环境的机制密切相关,通过探讨两者的关系,诠释癌毒病机理论的科学内涵,为临床运用癌毒病机理论指导中医药抗肿瘤提供科学依据。

     

  • [1] 孙燕.肿瘤内科治疗的新标杆——中西医融合 走向个体化[J].中国新药杂志,2010,19(17):1484-1488.
    [2] Sun Y. New Benchmark of Medical Treatment of Tumor-Personalization of the combination of TCM and western medicine[J]. Chin J New Drugs, 2010,19(17):1484-1488.
    [3] 程海波,吴勉华.周仲瑛教授“癌毒”学术思想探析[J].中华中医药杂志,2010,25(6): 866-869.
    [4] 〖JP2〗Cheng HB, Wu MH. Study on Theory of Cancerous Toxin of Professor Zhou Zhongying [J]. Chin J Tradit Chin Med Pharm, 2010, 25(6): 866-869.〖JP〗
    [5] Kenny PA, LG, Bissell MJ.Targeting the tumor microenvironment[J]. Front Biosci,2007,12: 3468-3474.
    [6] Cynthia EW,Paul CK.The tumor microenvironment[J].Surgical Oncology,2011,9:1-6.
    [7] Albini A, Magnani E, Noonan DM. The tumor microenvironment: biology of a complex cellular and tissue society[J]. Q J Nucl Med Mol Imaging, 2010, 54(3): 244-248.
    [8] 〖JP2〗周红光,陈海彬,吴勉华,等.消癌解毒方配合化疗治疗中晚期恶性肿瘤临床疗效观察[J]. 中华中医药杂志,2010,25(7): 1140-1143.〖JP〗
    [9] 〖JP2〗Zhou HG, Chen HB, Wu MH, et al.Observation on the combining treatment of Xiao'ai Jie Du decoction and chemical treatment in patients with middle and advanced period of malignant tumor[J]. Chin J Tradit Chin Med Pharm, 2010,25(7):1140-1143.〖JP〗
    [10] 陈海彬,沈波,李黎,等. 消癌解毒方抑制肝癌H22移植瘤的生长及其机制[J]. 中国肿瘤生物治疗杂志,2011,18(1):28-32.
    [11] 〖JP2〗Chen HB, Shen B, Li L, et al. Xiao'ai Jie Du decoction in inhibiting the development of transplanted tumor of liver cancer H22 and the mechanism[J]. Chin J Cancer Biotherap, 2011,18(1):28-32.〖JP〗
    [12] 巨大维,魏品康.清热解毒中药在恶性肿瘤防治中的药用机理与应用[J]. 吉林中医药, 2007,27(1): 60-62.
    [13] Ju DW, Wei PK. Medicinal mechanism and application of Chinese herbal medicine which can clear away heat and remove toxicity in treating malignant tumor[J].Jilin J Tradit Chin Med, 2007,27(1):60-62.
    [14] 吴勉华, 李栋.消癌解毒方加入脂多糖及CD284对人肝癌细胞SMMC-7721的TLRs/NF-κB信号转导通路TLR4等mRNA和蛋白表达的影响[J]. 中华中医药杂志,2012,27(12):3047-3051.
    [15] Wu MH, Li D.The influence of Xiao'ai Jie Du decoction with lipopolysaccharide and CD284 on human live cancerous cell SMMC-7721's TLRs/NF-κB signal TLR4 and the expression of mRNA and protein[J]. Chin J Tradit Chin Med Pharm, 2012, 27(12):3047-3051.
    [16] 王生,赵杨,陶丽,等. 靶向纤溶系统活血化瘀药的抗肿瘤活性研究进展[J]. 中草药,2012,43(6):1213-1217.
    [17] Wang S, Zhao Y, Tao L, et al. Advance in targeted medicine which can regulate blood and remove blood stasis in treating tumor[J].Chin Herb Med, 2012,43(6):1213-1217.
    [18] 王国娟,孙珏,余文燕,等.化痰散结法治疗肿瘤的研究进展[J].中国实验方剂学杂志,2013,19(1):333-338.
    [19] Wang GJ, Sun Y, Yu WY, et al. Advance in Hua Tan San Jie method in treating tumor[J]. Chin J Exper Tradit Med Form,2013,19(1):333-338.
    [20] 李志鹏,周洁.化痰药物治疗恶性肿瘤的研究[J].长春中医药大学学报,2011,27(4):673-674.
    [21] Li ZP, Zhou J. Advance in expectorants in treating malignant tumor[J]. J Changchun Univ Chin Med,2011,27(4):673-674.
    [22] 张玉,吴勉华,陈海彬,等. 消癌解毒方体内抑瘤作用机制研究[J].中国实验方剂学杂志,2011,17(11):234-237.
    [23] Zhang Y, Wu MH, Chen HB, et al. Study of Xiao'ai Jie Du decoction in inhibiting the tumor[J]. Chin J Exper Tradit Med Form, 2011,17(11):234-237
    [24] 胡作为,杨航.中药对肿瘤微环境影响的研究现状[J].湖北中医杂志,2013,35(9): 78 -82.
    [25] 〖JP2〗Hu ZW, Yang H. Research on TCM in treating tumor microenvironment[J]. Hubei J Tradit Chin Med, 2013, 35(9): 78-82.〖JP〗
    [26] 〖JP3〗李黎,沈波,陈海彬,等.消癌解毒方对H22荷瘤小鼠外周血清转化生长因子β1的影响[J].辽宁中医杂志,2011,38(11):2283-2284.〖JP〗
    [27] Li L, Shen B, Chen HB, et al.Influence of Xiao'ai Jie Du decoction on peripheral TGF of rats with H22 tumor[J]. Liaoning J Tradit Chin Med, 2011, 38(11): 2283-2284.
  • 加载中
计量
  • 文章访问数:  1021
  • HTML全文浏览量:  18
  • PDF下载量:  1141
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-11-12
  • 修回日期:  2014-01-28
  • 刊出日期:  2014-03-10

目录

    /

    返回文章
    返回